Literature DB >> 26921476

Gender-specific reference charts for cardiotocographic parameters throughout normal pregnancy: a retrospective cross-sectional study of 9701 fetuses.

Célia Amorim-Costa1, Joana Cruz2, Diogo Ayres-de-Campos3, João Bernardes4.   

Abstract

OBJECTIVE: To establish reference values for cardiotocographic (CTG) parameters from 24 to 41 weeks of gestation in normal pregnancies. STUDY
DESIGN: Retrospective cross-sectional study, using the first antepartum tracing of singleton fetuses with normal pregnancy outcomes (term birth, normal birthweight, normal umbilical artery pH and Apgar scores, no intensive care unit admission). Cases were consecutively selected from a hospital electronic patient record, and analyzed using the OmniviewSisPorto 3.7 system. Variables were compared between male and female fetuses, by gestational age, and percentile curves were constructed.
RESULTS: A total of 9701 tracings (corresponding to 9701 fetuses) were analyzed. All CTG parameters changed significantly throughout gestation in both genders, with a decrease in baseline and decelerations, and an increase in average long-term variability (LTV), average short-term variability (STV), accelerations and uterine contractions. The mean baseline value decreased 9bpm, and its range almost doubled from 24 to 40 weeks. Until 30 weeks the lower percentiles for average LTV were below 5bpm, and the minimum value for average STV was never below 1bpm. The proportion of tracings without accelerations decreased from 30.1% at 24-25 weeks to 0.5% at 39 weeks. The median number of decelerations was practically zero for all gestational ages. All CTG variables, except decelerations and uterine contractions, showed statistically significant gender differences: baseline was consistently higher in females, while average LTV and average STV tended to be lower in females throughout most of pregnancy. Separate percentile curves were constructed for male and female fetuses.
CONCLUSION: This study provides reference values for CTG parameters throughout pregnancy, derived from the largest dataset of healthy fetuses published to date. For the first time, gender differences were clearly demonstrated in fetal life, and percentile curves constructed separately for male and female fetuses.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antepartum; Cardiotocography; Fetal heart rate; Gender; Gestational age

Mesh:

Year:  2016        PMID: 26921476     DOI: 10.1016/j.ejogrb.2016.01.036

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Circadian changes and sex-related differences in fetal heart rate parameters.

Authors:  Habiba Kapaya; Fiona Broughton Pipkin; Barrie Hayes-Gill; Pamela V Loughna
Journal:  Matern Health Neonatol Perinatol       Date:  2016-09-02

2.  Comparison of diurnal variations, gestational age and gender related differences in fetal heart rate (FHR) parameters between appropriate-for-gestational-age (AGA) and small-for-gestational-age (SGA) fetuses in the home environment.

Authors:  Habiba Kapaya; Richard Jacques; Dilly Anumba
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

3.  Sex differences in umbilical artery Doppler indices: a longitudinal study.

Authors:  Christian Widnes; Kari Flo; Tom Wilsgaard; Torvid Kiserud; Ganesh Acharya
Journal:  Biol Sex Differ       Date:  2018-04-18       Impact factor: 5.027

4.  Fetal heart rate, heart rate variability, and heart rate/movement coupling in the Safe Passage Study.

Authors:  Lauren C Shuffrey; Michael M Myers; Hein J Odendaal; Amy J Elliott; Carlie du Plessis; Coen Groenewald; Larry Burd; Jyoti Angal; J David Nugent; Joseph R Isler; William P Fifer
Journal:  J Perinatol       Date:  2019-03-04       Impact factor: 2.521

Review 5.  Effect of Fetal Sex on Maternal and Obstetric Outcomes.

Authors:  Mohammed Al-Qaraghouli; Yu Ming Victor Fang
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.